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TruePrime is a novel method for whole-genome
ampliﬁcation from single cells based on TthPrimPol
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Sequencing of a single-cell genome requires DNA ampliﬁcation, a process prone to
introducing bias and errors into the ampliﬁed genome. Here we introduce a novel multiple
displacement ampliﬁcation (MDA) method based on the unique DNA primase features of
Thermus thermophilus (Tth) PrimPol. TthPrimPol displays a potent primase activity preferring
dNTPs as substrates unlike conventional primases. A combination of TthPrimPol’s unique
ability to synthesize DNA primers with the highly processive Phi29 DNA polymerase
(F29DNApol) enables near-complete whole genome ampliﬁcation from single cells. This
novel method demonstrates superior breadth and evenness of genome coverage, high
reproducibility, excellent single-nucleotide variant (SNV) detection rates with low allelic
dropout (ADO) and low chimera formation as exempliﬁed by sequencing HEK293 cells.
Moreover, copy number variant (CNV) calling yields superior results compared with random
primer-based MDA methods. The advantages of this method, which we named TruePrime,
promise to facilitate and improve single-cell genomic analysis.
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I
t has become apparent in the last 5 years that genomic analysis
of single cells provides crucial information that is lost in
bulk sequencing of tissue because of averaging effects and
limitations of computational methods to deconvolute sequence
information from many different clones1,2. For example, the
complexity of alterations of the cancer genome has only been
grasped recently by assessing single tumour cells in parallel3–5.
Especially for oncology, single-cell sequencing offers novel
insights into the evolution of cancers over time and in reaction
to treatment, which will lead to novel strategies for treatment
regimens and drug development6. Other application areas for
single-cell sequencing are pre-implantation diagnostics7–9 and
basic biological research, for example, in the neurosciences10.
Ampliﬁcation of genomic DNA is a necessary ﬁrst step for
the available sequencing technologies. Unfortunately, DNA
ampliﬁcation is a process subject to bias introduction, error and
co-ampliﬁcation of minute levels of contaminating DNA. Several
techniques have been developed for whole genome ampliﬁcation
(WGA), broadly dividable into PCR-related protocols and those
based on multiple displacement ampliﬁcation (MDA). PCR-based
methods can be classiﬁed into degenerate oligonucleotide-primed
PCR (DOP-PCR)11, linker-adapter PCR12, primer extension pre-
ampliﬁcation PCR (PEP-PCR-/I-PEP-PCR)13,14 and variations
thereof. MDA methods are mainly based on using the highly
processive F29DNApol15 together with random hexamers16–19.
There is another variant MDA method called pWGA based on
the reconstituted T7 replication system20. Recently, another
hybrid PCR/MDA method called multiple annealing and looping-
based ampliﬁcation cycles (MALBAC) has been proposed, relying
on the Bacillus stearothermophilus polymerase for the MDA
process21. Key parameters that determine the quality of the
ampliﬁcation are the absence of contaminations and artefacts in
the reaction products, coverage breadth and uniformity,
nucleotide error rates and the ability to recover single-
nucleotide variants (SNVs), copy number variants (CNVs) and
structural variants. In general, PCR-based methods are thought to
have advantages in CNV detectability22, whereas F29DNApol-
based methods have the advantage of extremely low nucleotide
error rates due to the high ﬁdelity of the polymerase, produce
very long ampliﬁcation products and cover the genome more
completely. Problems that affect all ampliﬁcation methods to
some degree are chimera formation and preferential ampliﬁcation
of one allele (allelic dropout, ADO).
A source for potential ampliﬁcation bias in the current
F29DNApol-based MDA methods is the propensity to
generate primer-derived artefacts and priming inequality arising
from different sequence-dependent hybridization kinetics of the
oligonucleotides. Thus, using a dedicated primase may provide an
advantage over random oligonucleotides. However, most known
primases only accept NTPs and generate RNA primers. These
RNA primers are not an ideal substrate for most replicative DNA
polymerases and need to be elongated by specialized transition
DNA polymerases, as DNA polymerase-a in human cells.
Primases can be divided into two evolutionarily unrelated
families: DnaG-like primases (Bacteria) and archaeal-eukaryotic
primase (AEP)-like primases (Archaea and Eukaryotes)23,24.
Recently, a novel subfamily of AEPs called primase-polymerase
(PrimPol)25,26 has been described, whose ﬁrst members were
originally found in archaeal plasmids27 and in some bacteria28.
PrimPols show both DNA polymerase and DNA primase
activities, and are often associated to helicases, to form a
replication initiation complex26,28,29. These features enable a
system where the same enzyme performs both the initiation
and elongation stages. Perhaps the most signiﬁcant feature
of PrimPols, unlike conventional primases, is their ability to
carry out the initiation and extension of DNA chains27,30–32.
More recently, PrimPol was described to exist in human cells
(HsPrimPol, UniProtKB Q96LW4), encoded by the PRIMPOL
gene (also known as CCDC111)33–36.
In this case, HsPrimPol is not associated to a helicase, but
displays some strand-displacement capacity. Moreover, its DNA
polymerase activity is able to efﬁciently bypass different kind of
DNA lesions as 8oxoG and pyrimidine dimers34,35,37–39. It is very
likely to be that this translesion synthesis capacity is crucial for
the demonstrated role of human PrimPol in mitochondrial DNA
maintenance34. Moreover, the most signiﬁcant feature of human
PrimPol (also extending to archaeal and bacterial PrimPols) is the
ability to initiate the synthesis of DNA chains (as a DNA
primase), unlike conventional primases that need NTPs to make
primers26–28,34. Such convenient capacity was shown to be
required to re-prime arrested replication forks during nuclear
DNA replication in human cells35,36,40 and also conﬁrmed in
avian cells41.
From a biotechnological perspective, the unique ability to
synthesize DNA primers could make PrimPol a useful partner
in an MDA-type process. Here we describe the cloning and
characterization of the Thermus thermophilus PrimPol enzyme
and the creation of a novel primer-free WGA method with
speciﬁc advantages for single-cell genome ampliﬁcation, which we
termed TruePrime.
Results
TthPrimPol is a DNA primase with wide template speciﬁcity.
Human PrimPol was initially considered as a good candidate for
DNA ampliﬁcation processes. However, the human protein was
promptly discarded mainly due to stability issues, probably
related to the presence of a Zn-ﬁnger domain at its carboxy
terminus and also due to its strong dependence on Mn2þ ions to
activate its priming function34. We therefore sought to identify a
more stable bacterial orthologue, with optimal enzymatic
properties to be exploited for biotechnological applications.
Search of the non-redundant database of protein sequences
(National Center for Biotechnology Information, NIH, Bethesda),
performed using the BLASTP programme42 revealed that the
hypothetical conserved protein AAS81004.1 (291 amino acids)
from T. thermophilus strain HB27 contained a PrimPol domain of
the type found in bifunctional replicases from archaeal plasmids.
Although conventional AEP-like primases, as human Prim1, have
the three conserved motifs (A, B and C) that form the primase
active site, the PrimPols already characterized have the same
three conserved motifs but also a Zn-ﬁnger domain required
for the DNA primase activity34–36. Strikingly, the putative
T. thermophilus PrimPol contains only the three motifs but no
Zn-ﬁnger domain (Fig. 1a). Instead, TthPrimPol contains an
a-helical PriCT-1 domain, found at the C-terminal of some AEP
primases24. A detailed amino acid sequence alignment (Fig. 2) of
TthPrimPol with its closest bacterial relatives and also with the
well-characterized pRN1 PrimPol, and some representatives of
other AEP-like members found in archaea, bacteria, phages and
plasmids, supports the correct identiﬁcation of PrimPol in
T. thermophilus (see legend to Fig. 2 for further details).
A more extensive search of the closest TthPrimPol orthologues
was carried out, supporting their conservation and monophyletic
origin in Bacteria (Supplementary Fig. 1). Moreover, the
signiﬁcant amino acid sequence similarity with pRN1 PrimPol
and also with the polymerization domain (PolDom) of
Mycobacterium tuberculosis LigD (not shown), whose three-
dimensional (3D) structures have been solved26,43,44, was
sufﬁcient to generate a 3D model for TthPrimPol in complex
with DNA and nucleotide substrates (Fig. 1b; see Methods for
details).
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TthPrimPol was cloned, expressed and puriﬁed in a soluble
and active form, as described in Methods. Primase activity was
ﬁrst analysed at 55 C using a single-stranded template
oligonucleotide in which a potential primase recognition
sequence 30-GTCC-50 is ﬂanked by thymine residues34,
according to the preferred template context to initiate primer
synthesis by several viral, prokaryotic and eukaryotic RNA
primases34–36. TthPrimPol displayed a strong primase activity,
starting synthesis opposite the ‘TC’ template sequence. The
nucleotide acting as ‘nano-primer’ (50-position)38 can be either a
ribonucleotide (ATP) or a deoxynucleotide (dATP) in the
presence of manganese, but only a deoxynucleotide (dATP)
when magnesium is the metal cofactor (Fig. 3a, left panel).
Second and further added nucleotides (30-position) must be
strictly deoxynucleotides (dGTP and dATP), regardless of the
metal cofactor present. Modiﬁcation of the base preceding
the directing TC template sequence had a minor effect on the
priming activity of TthPrimPol (Fig. 3a, right panel), in contrast
to the strong preference for 30-GTCC-50 shown by human
PrimPol34. TthPrimPol was able to initiate DNA primer synthesis
also at 30 C at multiple sites on a single-stranded circular DNA
template (M13mp18) by using both purine and pyrimidine
nucleotides to form the initial dimer (Fig. 3b), in agreement with
a desirable and wide template speciﬁcity, unlike human PrimPol
that largely prefers to make dimers with purine nucleotides34.
The preference for dNTPs as incoming nucleotides also makes
TthPrimPol a competent DNA-directed DNA polymerase, able
to extend the initiating dimers into longer DNA primers. By
providing the four dNTPs, TthPrimPol synthesized primers up to
20-mer (Fig. 3c, lane 3). Heparin, in an amount that can inhibit
TthPrimPol when pre-incubated (Fig. 3c, lane 2), was only able to
inhibit the synthesis of primers longer than 10 nucleotides, when
added after enzyme/DNA binding (Fig. 3c, lane 4). Thus, the
main primer products (7–9 nt) are synthesized processively, but
further extension appears to be distributive.
TthPrimPol serves as primase for U29DNApol-mediated MDA.
Having established that TthPrimPol is indeed a DNA primase,
we explored the possibility that these DNA primers could be
efﬁciently elongated by a second polymerase, the high-ﬁdelity
F29DNApol45. We designed a ﬁrst experiment in two steps
(pulse and chase), to interrogate about the size of the primers
made by TthPrimPol that can be efﬁciently extended by
F29DNApol. First, during the pulse, TthPrimPol generated
labelled primers at different enzyme/DNA ratios, supporting
that 7–9 nt primers are the main products, processively
synthesized (Fig. 3d, left panel). During the chase at 10 mM
dNTPs, F29DNApol was able to generate highly elongated
products by extending these primers (Fig. 3d, right panel).
Thus, the compatibility of both enzymes allowed their
combination to perform rolling circle ampliﬁcation (RCA)46 on
a single-stranded M13mp18 template, as an alternative method
(that we termed TruePrime) to the currently used mix of random
primers (RPs) and F29DNApol (Fig. 4a). As a control, none of
the enzymes by itself was able to amplify the target. Of note, also
human PrimPol was not able to cooperate with F29DNApol in
RCA, highlighting the unique primase features of TthPrimPol,
able to make DNA primers in the presence of Mg2þ , a metal
needed to achieve faithful DNA synthesis by F29DNApol. In
addition, WGA from human DNA yielded DNA amounts
comparable to RP-mediated ampliﬁcation (Fig. 4b). The size
distribution of the resulting DNA showed a broad high-molecular
weight pattern as also seen with RPsþF29DNApol (Fig. 4c).
Sensitivity of TruePrime for low-input amounts of target DNA
was excellent, in the range of femtograms, and superior to the
RP-mediated ampliﬁcation (Fig. 4d). The reaction output of the
TthPrimPol/F29DNApol combination was shown to be target
derived: even at 1 fg input 495% of the sequences could be
mapped to the human genome (Supplementary Fig. 2).
TruePrime WGA yields high-quality genomic sequences. We
next applied this novel WGA method to the ampliﬁcation of
genomic DNA from single human HEK293 cells isolated by serial
dilution, manual picking and visual inspection, and subjected
them to the TruePrime protocol (see Methods) for 3 or 6 h
reaction time. Yields obtained wereB6mg for 3 h andB10mg for
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Figure 1 | A putative PrimPol in T. thermophilus. (a) Modular organization of various AEP-like enzymes. A conserved AEP domain (green bar) contains the
three conserved regions A, B and C forming the primase active site. Unlike conventional primases as HsPrim1, PrimPols frequently have a Zn-ﬁnger-
containing region (HsPrimPol) or even a helicase domain (BcMCM PrimPol; Si/pRN1 PrimPol). A putative AEP-like enzyme in T. thermophilus lacks both Zn
ﬁnger and helicase domain; however, its C-terminal domain contains a PriCT-1 domain characteristic of some prokaryotic primases, also shared by BcMCM
and Si/pRN1 PrimPols (see later in b). Nomenclature: small catalytic subunit of the human RNA primase (HsPrim1); human PrimPol (HsPrimPol); PrimPol-
helicase from Bacillus cereus (BcMCM); plasmid pRN1 ORF904 from Sulfolobus islandicus (Si/pRN1 PrimPol); putative PrimPol from T. thermophilus
(TthPrimPol). (b) 3D structure of TthPrimPol. The computer-modelled crystal structure of TthPrimPol (amino acids 4–208 modelled as described in
Methods) is depicted in ribbon format by using the graphic program PyMol. a-Helices are green (lettered), b-strands are orange (numbered) and
intervening loop regions are grey; metal ligands (Asp70, Asp72 and Asp123) are shown in red; dNTP ligand (His101) is shown in purple; DNA template
(dark purple) and primer (blue) strands, activating metals (grey spheres) and incoming nucleotide (cyan) are derived from 3D structures of M. tuberculosis
PolDom Ligase D (4MKY and 3PKY).
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Figure 2 | Multiple amino acid sequence alignment of the closest TthPrimPol orthologues. The ﬁrst block of sequences corresponds to Thermales
(Thermus and Meiothermus) and the second block includes Si/pRN1 PrimPol and some other putative bifunctional primases/polymerases from bacteria,
archaea and phage; in addition, plasmidic Rep (a potential PrimPol) and BcMCM PrimPol were included. Numbers in parentheses indicate the number of
amino acid residues not shown. Invariant or conserved residues among Thermales (ﬁrst set of sequences) were labelled in red and blue letters, respectively.
Identity matches in the second set of sequences were equally coloured. The alignment deﬁnes several conserved regions, including the highly conserved
motifs A, B and C (boxed in yellow), characteristic of AEP-like primases. Experimentally determined secondary structure elements in Si/pRN1 PrimPol are
indicated above pRN1 sequence (a-helices, lettered cylinders; green) and b-strands (numbered arrows; orange). Modelled secondary structure elements in
TthPrimPol are tentatively depicted above the TthPrimPol sequence (see also Fig 1b). The corresponding aligned regions are boxed in the same colours to
emphasize structural conservation between TthPrimPol and the AEP core of pRN1. The C-terminal region of TthPrimPol, conserved in other Thermales
(boxed in grey), aligns with the PriCT-1 domain of Rep and Eph primases; this region is not yet crystallized in pRN1 and it has been described as
pRN1_helical29. Dots indicate invariant residues acting either as metal (red), nucleotide (purple) or Zn (magenta) ligands. Selection of the closest
TthPrimPol homologues and multiple alignment of their amino acid sequence were initially performed with the BLAST programme and further adjusted
manually to maximize similarities with the structured regions of pRN1 PrimPol. Nomenclature: YP_004631.1 T. thermophilus (Tth); YP_006971229.1 Thermus
oshimai (Tos); WP_003046664.1 Thermus aquaticus (Taq); YP_004202830.1 Thermus scotoductus (Tsc1); YP_004202855.1 T. scotoductus (Tsc2);
ETN89075.1 Thermus sp (Tsp); YP_003508539.1 Meiothermus ruber (Mru); YP_003684976.1 Meiothermus silvanus (Msi1); YP_003684747.1 M. silvanus
(Msi2); AAC44111.1 plasmid pRN1 ORF904 from S. islandicus (pRN1); YP_502469.1Methanospirillum hungatei (Mhu); YP_006262572.1 Deinococcus gobiensis
(Dgo); YP_002829910.1 S. islandicus (Sis); YP_003357218.1 Methanocella paludı´cola (Mpa); AFO10831.1 Enterococcus phage EfaCPT1 (Eph);
YP_009074444.1 Shigella sonnei Rep protein from plasmid ColE4-CT9 (Rep); WP_044797243 PrimPol-helicase from B. cereus (BcMCM).
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6 h as quantiﬁed by Picogreen. Limited sequencing of DNA
obtained from four cells was carried out in comparison with DNA
isolated from the originating bulk cells (non-ampliﬁed, NA). In
parallel, single cells were ampliﬁed using a commercially available
MDA kit (REPLI-g Single Cell Kit, Qiagen, Aarhus, Denmark),
or by using our TruePrime protocol, but exchanging TthPrimPol
for random hexamers (generic RP-MDA). In addition, we ampliﬁed
a single HEK293 cell by the MALBAC protocol21 as a hybrid MDA
method. Fragment sizes for the ampliﬁed DNA wereB9–19kb for
the commercial RP-MDA, 1.5–12kb for TruePrime and 0.5–1.5 kb
for MALBAC (Supplementary Fig. 3). DNA was sequenced using a
paired read strategy (Illumina HiSeq, 125 bp read length).
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Figure 3 | TthPrimPol is a DNA primase that can be coupled to processive elongation by U29DNApol. (a) Left panel: metal and sugar selectivity of
TthPrimPol primase activity. 30-GTCC-50 oligonucleotide (1mM) was used as a preferred template. Labelled nucleotide [g-32P] ATP or [a-32P] dATP nM)
were alternatively used as 50-nucleotide and either unlabelled GTP or dGTP (10 mM) were tested as 30-nucleotide to form the initiating dimer. Primer
synthesis mediated by TthPrimPol (400nM) was evaluated either with 1mM MnCl2 or 5mM MgCl2 at 55 C during 60min. Right panel: recognition of the
priming site. The assay was as in the left panel, but using templates differing in the base preceding the primase initiation site (yXTCCy) and the
indicated metal and nucleotides. (b) TthPrimPol-mediated DNA primer synthesis at 30 C occurs at multiple sites on a heterogeneous ssDNA template.
TthPrimPol (100 nM) was able to generate DNA primers on circular M13mp18 ssDNA (5 ngml 1), when using four alternative combinations of dNTPs,
implying that initiation occurred at multiple sites. In all cases, [a-32P] dGTP (16 nM) was provided to label the nascent primers, combined with either dATP,
dCTP, dGTP or dTTP (1 mM), in the presence of 10mMMgCl2 at 30 C during 20min. (c) To evaluate the processivity of primer synthesis by TthPrimPol, we
used heparin as a competitor. TthPrimPol (10 nM) was preincubated for 5min on ice, either in the absence/presence of heparin (1 ng ml 1). Subsequently,
the reaction was complemented with M13mp18 ssDNA (5 ng ml 1), dATP, dCTP and dTTP (10 mM each), [a-32P] dGTP (16 nM; 3,000Cimmol 1) and
heparin (1 ngml 1) when indicated and the incubation was maintained for 10min at 30 C, and processed as described. (d) TthPrimPol-synthesized DNA
primers are efﬁciently extended by F29DNApol. The contribution of each enzyme was assayed in two consecutive stages (pulse and chase), as indicated in
the scheme. The pulse demonstrated the synthesis of primers with a mean size of 7–9 nt (left panel). During chase (right panel), F29DNApol generated
high-molecular-weight primer-elongated products (detected at the top of the gel) and some degradation products (evidenced at the bottom).
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Comparison of mapping characteristics of these samples was
done at exactly 12 million randomly selected read pairs for NA
DNA, TruePrime-ampliﬁed DNA, the two RP-MDA protocols
and MALBAC. We calculated the deviation of the actual fraction
of the human genome covered from the theoretically possible
fraction covered assuming an ideal Poisson distribution for the
successfully mapped reads47. Theoretically expected coverage
rates varied because of differing success rates in mapping the
12 million read pairs to the genome (NA DNA 92.03%,
TruePrime 86.77%, Commercial random primed MDA 91.50%,
Generic random primed MDA 59.07%, MALBACs 89.68%).
In addition, we adjusted the expected maximal coverage to the
duplicate rate, which was 1.79% in the NA sample, 1.23% in the
TruePrime sample, 1.33% in the commercial RP-MDA sample,
9.53% in the generic RP-MDA sample and 0.23% for MALBAC.
The deviations from the observed to the maximally expected
(Poisson) coverage breadth were 9.17% for NA DNA, 13.15% for
TruePrime, 34.83% for the commercial RP-MDA, 30.73% for the
generic RP-MDA and 46.89% for MALBAC at this read depth.
Visual inspection of the coverage pattern across the genome by a
Circos plot (Fig. 5a) as well as by a sliding window view on
chromosome 4 (Fig. 5b and Supplementary Fig. 4) highlights the
evenness of coverage and the high similarity to the NA material in
contrast to the two RP-MDA methods and MALBAC. Graphing
read depth frequency also shows the similarity of the TruePrime
ampliﬁed sample to the NA one (Fig. 5c).
We studied terminal breadth of coverage in one of the
ampliﬁed genomic samples (1c), the commercial RP-MDA
sample, the NA reference DNA and MALBAC at high
sequencing depth. The NA sample reached a genome coverage
of 19.19-fold with 91.64% of the human genome (hg19) covered,
the TruePrime-ampliﬁed sample had a genome coverage of
19.65-fold with a fractional coverage of 91.26% relating to an
absolute difference in bases with 0 coverage of 11.7 million
(Table 1). In comparison, the commercial RP-MDA method
reached 85.57% genome coverage breadth at comparable read
depth and MALBAC reached 58.57% coverage breadth.
Nucleotide error rates in the reads were similar between the four
samples (Table 1).
We also looked at coverage breadth saturation with increasing
read input at a minimum coverage of 1 (Fig. 5d, upper panel)
and the deviation from the expected coverage using a Poisson
distribution model (Fig. 5d, middle panel). The last panel in
Fig. 5d shows the saturation of genome coverage breadth at a
minimal coverage depth of 10 . The TruePrime-ampliﬁed
sample shows the highest similarity in all analyses to the NA
material.
Relative coverage per chromosome is in general similar
between the NA sample and TruePrime but with visible exception
for some chromosomes that show a relatively lower coverage by
TruePrime (for example, 19 and 22; Fig. 5e). We investigated
whether this was related to the varying GC content between
human chromosomes. The notable difference between chromo-
somal coverage in the NA sample is due to some other basic bias
in the library prep or Illumina sequencing protocol, as the effect
of GC content on chromosomal coverage does not reach
signiﬁcance (P¼ 0.12; Supplementary Fig. 5a). In the True-
Prime-ampliﬁed sample there is a signiﬁcant effect of GC content
on chromosomal coverage (R2¼ 0.38; P¼ 0.0017; Supplementary
Fig. 5b). Surprisingly, the behaviour of the commercial MDA
(REPLI-g; Qiagen) is identical to this (R2¼ 0.44, P¼ 0.0006;
Supplementary Fig. 5c,d), implying that the main driver behind
this behaviour is F29DNApol, not the priming mechanism.
A regression model using both chromosomal GC content and the
variation of chromosomal coverage already present in the NA
sample fully explains the pattern of chromosomal coverage in
both ampliﬁed samples with an R2 of 0.94 (Po0.0001 for all
effects), meaning that there is an unexplained variance of only 6%
in this coverage behaviour. It is however important to note that
the chromosomal variation inherent in the sequencing process is
the most inﬂuential factor for the coverage pattern seen in the
ampliﬁed samples.
In general, read number frequency in dependence of GC
content appears similar between the NA and the TruePrime-
ampliﬁed sample (Fig. 5f), with the exception of a slight
preference of the TruePrime ampliﬁcation reaction for a GC
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range of 16–24%. MALBACs showed a right shift of the
distribution curve.
We assessed coverage characteristics at a sequencing depth of
B20 also by examining k-mer frequency distribution48
(Fig. 6). K-mer frequencies were calculated using jellyﬁsh49.
K-mer size was set to 19 as suggested by Kelley et al.50. For the
frequency plot shown the y axis was cut at 5% to show the higher
frequencies at greater detail. The fraction of K-mers at a
frequency of one (unique K-mers) was 34.36% for NA, 32.18%
for TruePrime, 49.12% for MALBAC and 45.19% for the
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commercial RP-MDA protocol; the fraction of K-mers with
frequencies of one or two was 36.32% for NA, 36.30% for
TruePrime, 60.80% for MALBAC and 52.12% for the commercial
RP-MDA protocol. Unique K-mer frequency is thought to be
mostly due to nucleotide errors, but can also arise from a high
fraction of very low coverage regions, which is possibly the
explanation for the higher unique K-mer content in the
commercial RP-MDA sample. On the other side, the identical
unique K-mer content in the NA and TruePrime-ampliﬁed
sample supports both the low nucleotide error rate of the
ampliﬁcation method and the even coverage obtained. The
bimodal distribution of K-mer frequencies in the human genome
is completely lost in the commercial RP-MDA and the MALBAC
sample, also most likely to be the effect of coverage inequality,
whereas the distribution of the higher frequency k-mers is very
similar between NA and TruePrime (peak depth 16 for NA, 13 for
TruePrime).
Next, we looked at the reproducibility of the ampliﬁcation
results. Figure 7a shows a Circos plot of genome coverage from
NA material (grey) and four single HEK293 cells ampliﬁed with
TruePrime (blue) (input: exactly ﬁve million randomly selected
read pairs). The fraction of the genome covered at this read
number was 28% for the NA sample and between 26 and 28% for
all 4 cells ampliﬁed. Cross-correlation between read numbers per
100 kb bin (Fig. 7b) and a sliding window view on chromosome 4
(Fig. 7c) highlight the similarity between the four replicates.
Table 1 | Mapping and coverage parameters at high sequencing depth.
NA TruePrime (1c) Commercial RP-MDA MALBAC
Mapping characteristics
Total read count 509,313,411 536,789,206 560,053,809 527,319,977
Total read length 64,173,489,786 67,635,439,956 70,566,779,934 66,442,317,102
Total reference length 3,095,693,983 3,095,693,983 3,095,693,983 3,095,693,983
Formal average coverage 20.61 21.64 22.54 20.22
Reads in aligned pairs 471,412,468 482,799,006 504,010,950 478,462,898
Reads in broken pairs: wrong distance or mate inverted 11,768,592 31,849,758 31,794,142 18,026,124
Duplicates (%) 1.79 1.23 1.33 0.27
Zero coverage
Count 77,214 173,115 1,251,358 2,704,811
Minimum length 1 1 1 1
Maximum length 30,000,187 30,000,464 30,011,442 30,001,753
Mean length 3,351 1,562 357 470.79
Standard deviation 210,644 140,690 52,335 35,645.23
Total length 258,761,464 270,454,431 446,801,369 1,273,398,011
Average coverage (true) x-fold 19.19 19.65 20.51 19.47
Genome fraction covered (%) 91.64 91.26 85.57 58.87
Nucleotide errors (differing bases in %)
A in ref 0.63 0.87 0.45 0.81
C in ref 1.09 1.05 0.51 0.81
G in ref 0.83 0.94 0.51 0.81
T in ref 0.64 0.83 0.45 0.81
- in ref 0.73 0.26 3.03 2.89
Total nucleotide errors 0.77 0.83 0.50 0.85
MALBAC, multiple annealing and looping-based ampliﬁcation cycle; MDA, multiple displacement ampliﬁcation; NA, non-ampliﬁed.
The NA reference DNA and single HEK293 cells ampliﬁed with TruePrime, the commercial RP-MDA kit and MALBAC were sequenced at high depth, reaching a coverage of 19–20 genome equivalents
(mapped read pairs). The NA sample reached a genome coverage of 19.19 with 91.64% of the human genome covered; the TruePrime-ampliﬁed sample showed a genome coverage of 19.65 with a
coverage of 91.26% (absolute difference in zero coverage of 11.7 million bases). The commercial RP-MDA sample reached 85.57% and the MALBAC sample reached 58.87% genome coverage.
Figure 5 | Coverage comparison of PrimPol-mediated MDA of single cells to random primed MDA. Comparison of genome coverage of NA HEK293 cell
DNA and single human HEK293 cells ampliﬁed by either TruePrime, a generic RP-MDA, a commercial RP-MDA kit (REPLI-g single cell kit, Qiagen) or
MALBAC. (a) Circos plot showing genome coverage using exactly 12 million read pairs as input. From outward to inward: NA-sample (grey), TruePrime
(blue), commercial RP-MDA kit (orange), MALBAC (red) and generic RP-MDA protocol (yellow). Plot was generated using bin sizes of 50 kb. TruePrime
shows a more even coverage distribution compared with the other methods. (b) Sliding window coverage comparison of chromosome 4 between NA
(grey), TruePrime (blue), commercial RP-MDA kit (orange), MALBAC (red) and generic RP-MDA protocol (yellow). TruePrime shows a highly similar
coverage pattern compared with NA. The commercial RP-MDA kit, MALBAC and generic RP-MDA display a higher jitter. The y axis is cut at a read depth of
50. For a detailed close-up, see Supplementary Fig. 4. (c) Comparison of coverage depth frequency distribution between NA sample and ampliﬁed samples
(logarithmic y axis). The similarity of the TruePrime to the NA curves is noteworthy. (d) Coverage breadth saturation of human genome (fraction
covered¼ y axis) at a minimum coverage of 1 with increasing number of matched reads (x axis) (upper panel) and resulting deviation from expected
coverage using a Poisson distribution model (middle panel). The lower panel shows the saturation curve for a minimal coverage depth of 10 . The
TruePrime-ampliﬁed sample shows the highest similarity in all analyses to the NA material. (e) Coverage over different chromosomes (% chromosome
covered) for NA (grey), TruePrime (blue), commercial RP-MDA kit (orange) and MALBAC (red). Coverage of NA, TruePrime and commercial RP-MDA kit
are relatively similar, whereas MALBAC shows some differences and an overall lower coverage for some of the chromosomes. (f) Comparison of
GC-content dependency of read frequency between NA (grey), TruePrime (blue), the commercial RP-MDA kit (orange) and MALBAC (red). Again, the
behaviour between NA, TruePrime and commercial RP-MDA kit is very similar. MALBAC shows a right shift.
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CNV detection in single cells is of particular interest in
oncology. HEK293 cells have a partial aneuploidic state51 and
therefore CNV alterations should be detectable. Currently, a vast
variety of bioinformatic tools are available for CNV detection
based on different strategies52,53. We used both FREEC54 and the
recently published Ginkgo platform speciﬁcally optimized for
single-cell CNV detection55. Visual comparison of CNV plots
shows that TruePrime much better preserves the chromosomal
CNV state than both RP-MDA and MALBAC (Supplementary
Figs 6 (FreeC) and 7 (Ginkgo)). For Ginkgo, the median absolute
deviation (MAD) of all pairwise differences in read counts
between neighbouring bins55 calculated for single HEK293
ampliﬁed with TruePrime was B0.2, a number close to the
MAD value derived for published DOP-PCR ampliﬁed genomes,
and strikingly different from the MADs from published RP-MDA
methods that range between 0.35 and 0.8 (ref. 55).
Chimera formation is thought to be a problem in MDA
potentially arising by strand switching during the displacement
process56. We estimated the number of chimeras formed during
the ampliﬁcation process as the increase in broken read pairs due
to wrong distance or mate inversion in the ampliﬁed samples
relative to the NA sample. Although the NA sample had 2.5%
broken read pairs of this nature, the TruePrime-ampliﬁed
samples showed between 3.9 and 6.5%, suggesting that there is
an increase in chimeras generated by the TruePrime process in
the range of 2–3% over all read pairs. The commercial RP-MDA
protocol showed a similar fraction of broken read pairs due to
wrong distance or mate inversion (5%) as the TruePrime sample
implicating the same increase in chimeras and suggests that the
priming process has little inﬂuence on the occurrence of chimeras
in F29DNApol-mediated DNA ampliﬁcation protocols.
For SNV calling, we used four different SNV callers due to high
inter-caller variability57,58 (Supplementary Table 1). With the
exception of samtools/bcftools, all callers detected similar
numbers of SNVs with a median of 3.0Mio SNVs for the NA
and 2.7Mio SNVs for the TruePrime-ampliﬁed cell. The overlap
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between SNVs in the two samples was 2.4Mio, equivalent to 81%
of the SNVs found in the NA sample (Supplementary Table 1). In
contrast, in the cell ampliﬁed by the commercial RP-MDA
method, only 1.6Mio SNVs were detected of which 1.4Mio
overlapped with SNVs detected in the NA sample (45% of all NA
SNVs; Supplementary Table 1). This was even lower in
MALBAC, where only 30% of the SNVs detected in the NA
sample were recovered.
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Figure 8 | ADOs and CNVs. Circos plots showing heterozygote–homozygote conversion events (labelled as ‘ADO rates’) collected from different SNV
callers. From outward to inward: overall coverage as shown in Fig. 5 (bin size 50 kb, y axis from 0 to 2,500 reads), GC content, heterozygote–homozygote
conversion events calculated from samtools/bcftools, Isaac variant caller, CLC low frequency caller, varscan2 (bin size 100 kb, y axis range from 0 to 50)
and calculated ploidy state/CNVs using FreeC (bin size of 50 kb). The left Circos plot shows a genome-wide representation, the right Circos plot depicts
chromosome 6 only for (a) TruePrime versus none-ampliﬁed, (b) commercial RP-MDA kit versus NA and (c) MALBAC versus NA. Coverage and calculated
ploidy state reﬂect the ampliﬁed sample in each plot. TruePrime has a much lower number of ADOs than both the commercial RP-MDA kit and MALBAC.
Likewise, the CNVs detected in the commercial RP-MDA kit and MALBAC-ampliﬁed samples deviate clearly from the TruePrime sample. For details
regarding the CNVs in detail, see Supplementary Figs 6 and 7.
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A major question with WGA methods is the so-called ADO
rate, meaning the fraction of heterozygous SNVs that are lost due
to exclusive or predominant ampliﬁcation of only one allele. A way
to estimate this number is to establish the heterozygous SNVs in
the NA sample and determine the fraction that is called as
homozygous SNVs in the ampliﬁed sample. The overall number of
SNVs that were detected as heterozygous in the NA sample and
homozygous in the TruePrime-ampliﬁed sample (1c) ranged from
0.73% (Isaac SNV caller) to 8.42% (Varscan2) with a median of
5.95% across the whole genome (Supplementary Table 1),
suggesting an ADO of B1.45–15.5% with a median of 11.23%
(AB-4AA plus the non-observed AB-4BB). Interestingly, there
was a considerable degree of variation in the apparent conversion
rate among different chromosomes (Fig. 8). In contrast, the
commercial RP-MDA method showed a very high estimated ADO
rate of 45.74% (median of the 4 callers) similar to the MALBAC
method (47.22% in the median; Supplementary Table 1).
Related to the question of ADOs is the issue of false positives
that could be generated during the ampliﬁcation process.
The TruePrime false positive rate (FPR) for the SNVs based on
the overlap with the NA sample was around 1% for three of the
callers and 3.66% for samtools/bcftools (Supplementary Table 1).
The RP-MDA FPR was similar to that (Supplementary Table 1).
MALBACs showed the highest FPR with 5.9%. Another possibility
to detect generation of false positives is to determine the
conversion of homozygote alleles to heterozygotes for a haploid
chromosome (#18) in our HEK293 cell line. This ensures that the
homozygote calls from the NA DNA are true positives. The rates
here were 0.13–1.29% for TruePrime, depending on the caller, and
similar in the RP-MDA sample (Supplementary Table 1).
Discussion
Here we have cloned, characterized and put into technical use a
novel PrimPol, TthPrimPol. To our knowledge, this is the ﬁrst
instance that this class of enzymes has been made available for
biotechnological applications.
We have exploited several unique features of TthPrimPol for its
cooperation with F29DNApol, to enable successful WGA. First,
the ability to use dNTPs and synthesize DNA primers makes it
possible for the enzyme to work without addition of NTPs to the
reaction, which would alter DNA polymerase characteristics of
F29DNApol and would generate RNA/DNA chimeric molecules
with possible disadvantageous consequences for downstream
enzymatic manipulation for library construction and so on.
Second, TthPrimPol works with Mg2þ as the only metal ion and
does not need Mn2þ , which would interfere with the
high-ﬁdelity DNA synthesis by F29DNApol. Third, the primase
function of TthPrimPol synthesizes DNA primers of 7–9
nucleotides length in a processive mode, but then switches to a
distributive mode for its polymerase function, enabling the highly
processive F29DNApol to take over elongation of those primers.
This unique compatibility of the two enzymes thus enables
the replacement of the error-prone polymerase function of
TthPrimPol with the high-ﬁdelity F29DNApol for WGA (Fig. 9).
We ﬁnd that TruePrime has an exquisite breadth of coverage,
which approximates that of NA DNA (91.26% at B19
coverage). Breadth of coverage is a known strength of MDA-
based protocols including the hybrid MALBAC method5,21,59 as
opposed to purely PCR-based methods (DOP-PCR has only
B10% coverage breadth3,60) and reaches ranges of over 90%
genome coverage61. In our hands, the commercial RP-MDA
protocol gave a coverage breadth of B86%, whereas MALBAC
reached 59%. Together with the inherently high ﬁdelity of
F29DNApol of about 10 7 (ref. 18) and the high evenness of
coverage, this lays ideal foundations for high-quality SNV calling
throughout the genome of single cells. Indeed, we report an 80.6%
concordance of SNVs called in NA and ampliﬁed samples in the
range of expected SNV numbers. Our estimate for the ADO
number appears low (estimated at 11.23% in the median of four
a TthPrimPol binding
b Synthesis of short DNA primers
c Primer extension by Φ29DNApol
d Strand displacement DNA synthesis
by Φ29DNApol  
f Extension of new primers by
Φ29DNApol 
e New primers made by TthPrimPol on 
displaced ssDNA 
Figure 9 | Scheme of the TruePrime reaction. TruePrime reaction steps leading to ampliﬁcation of (genomic) DNA. (a) TthPrimPol binds to denatured
DNA at different sites. (b) TthPrimPol synthesizes short DNA primers. (c) DNA primers are recognized by F29DNApol, which replaces TthPrimPol
extending the primers. (d) DNA primer elongation coupled to strand displacement by F29DNApol leads to the exposure of new single-stranded template
regions. (e) TthPrimPol catalyses new rounds of priming on the displaced ssDNA. (f) New DNA primers trigger further rounds of strand-displacement
synthesis, leading to exponential ampliﬁcation of the target DNA.
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SNV callers and as low as 1.45% in the Isaac caller). Numbers in
the literature for MDA methods for single-genome cell
ampliﬁcation vary widely between 4 and 50% (refs 62–64), and
we ﬁnd a high estimated ADO for both RP-MDA and MALBAC
(445%). It is important to note that estimation of the ADO using
the heterozygote to homozygote conversion is also subject to the
variant caller used and the read depth at each SNV locus. We
attempted to address this issue by using four different callers and
reporting detailed output parameters. The much higher ADO in
the RP-MDA and MALBAC sample may be partially due to the
lower evenness in coverage, which results in more loci having
lower coverage and therefore having a higher chance of missing
one allele.
A weakness of the MDA group of methods despite the superior
breadth of genome coverage is CNV detection, in particular for
methods relying on read-depth counting. This is due to inequality
bias in amplifying different genomic regions. TruePrime has
considerably less ampliﬁcation bias than random primer-based
protocols and reaches the coverage dispersion characteristics
of DOP-PCR ampliﬁcation experiments from single cells.
Consequently, this allows for improved CNV detection accuracy,
thus improving one major weakness of F29DNApol/MDA-based
protocols so far.
Another reported problem with MDA methods concerns
chimera formation occurring by strand switching during strand
displacement. We ﬁnd that percentage of broken read pairs
probably due to chimeras is at a 2–3% percentage fraction of
reads. In summary, TruePrime presents an important improve-
ment to F29DNApol-mediated ampliﬁcation of single-cell
genomes. We believe that this method will contribute greatly to
the accessibility of genomic information from single cells.
Methods
Computational modelling of TthPrimPol 3D structure. The 3D structure of
TthPrimPol was modelled using as template the crystallographic structure of the
DNA primase/polymerase domain of ORF904 from the archaeal plasmid pRN1
(PDB ID:3M1M and 1RNI). TthPrimPol amino acid residues 4 to 166 were
modelled with the Phyre2 (ref. 59) online server using 3M1M as template;
TthPrimPol amino acid residues 167 to 208 were modelled with the DeepView
Project Mode of Swiss Model65 online server using 1RNI as template. DNA
template and primer strands, metals and incoming nucleotide were modelled using
two crystal structures of the polymerase domain (PolDom) of M. tuberculosis ligase
D (PDB ID:4MKY for template/primer and PDB ID:3PKY, for metals and
incoming nucleotide), which were ﬁtted to the TthPrimPol model by using the
three invariant catalytic aspartates (motifs A and C) and the invariant histidine
(at motif B) as reference coordinates. The image depicted in Fig. 1b was created
with the PyMol Molecular Graphics System (version 1.2r3pre, Schro¨dinger, LLC),
omitting the amino acid sequence information from the LigD PolDom crystals.
Cloning of TthPrimPol. Sequence analysis of the T. thermophilus HB27 genome
(DDBJ/EMBL/GeneBank AE017221.1; GI:46197919) revealed the ORF TTC0656,
encoding a protein that belongs to the AEP superfamily. Using this sequence
information, we synthesized two primers (50-ccggcccatatgaggccgattgagcacgccc-30
and 50-gcgcgcgaattctcatacccacctcctcatccggg-30) for ampliﬁcation of the TthPrimPol
gene by PCR from T. thermophilus genomic DNA. The gene fragment ampliﬁed by
PCR using Expand High Fidelity polymerase (Roche Diagnostics, Mannheim,
Germany) was ligated into the pGEM T-easy vector (Promega, Madison, WI, USA)
by TA cloning and conﬁrmed by sequencing. Using the NdeI and EcoRI sites,
the fragment bearing the target gene was ligated into pET28 vector (Novagen,
Merck-Millipore, Billerica, MA, USA), allowing the expression of TthPrimPol fused
with a multifunctional leader peptide containing a hexahistidyl sequence for
puriﬁcation on Ni2þ -afﬁnity resins.
TthPrimPol production. Expression of TthPrimPol was carried out in the E. coli
strain BL21-CodonPlus (DE3)-RIL (Stratagene), with extra copies of the argU, ileY
and leuW transfer RNA genes. Expression of TthPrimPol was induced by the
addition of 1mM isopropyl-b-D-thiogalactoside to 1.5 l of log phase E. coli cells
grown at 30 C in lysogeny broth (LB) to an Abs600 nm of 0.5. After induction, cells
were incubated at 30 C for 5 h. Subsequently, the cultured cells were harvested and
the pelleted cells were weighed and frozen ( 20 C). Just before puriﬁcation,
which was carried out at 4 C, frozen cells (3.5 g) were thawed and resuspended in
20ml buffer A (50mM Tris-HCl pH 7.5, 5% glycerol, 0.5mM EDTA and 1mM
dithiothreitol (DTT)) supplemented with 1M NaCl, 0.25% Tween-20 and 30mM
imidazole, and then disrupted by sonication on ice. Cell debris and insoluble
material were discarded after a 50min centrifugation at 40,000 g. The supernatant
was loaded into a HisTrap crude FF column (5ml, GE Healthcare) equilibrated
previously in buffer A supplemented with 1M NaCl, 0.25% Tween-20 and 30mM
imidazole. After exhaustive washing with buffer A supplemented with 1M NaCl,
0.25% Tween-20 and 30mM imidazole, proteins were eluted with a linear gradient
of 30–250mM imidazole. The eluate containing TthPrimPol was diluted with
buffer A supplemented with 0.25% Tween-20 to a ﬁnal 0.1M NaCl concentration
and loaded into a HiTrap Heparin HP column (5ml, GE Healthcare), equilibrated
previously in buffer A supplemented with 0.1M NaCl and 0.25% Tween-20. The
column was washed and the protein eluted with buffer A supplemented with 1M
NaCl and 0.25% Tween-20. This fraction contains highly puriﬁed (499%)
TthPrimPol. Protein concentration was estimated by densitometry of Coomassie
Blue-stained 10% SDS–polyacrylamide gels, using standards of known concentra-
tion. The ﬁnal fraction, adjusted to 50% (v/v) glycerol, was stored at  80 C.
Primase assays. 30-GTCC-50 oligonucleotide (1mM) or its variant XTCC
oligonucleotides (1 mM) or M13mp18 single-stranded DNA (ssDNA) (20 ng ml 1)
were used as alternative templates to assay primase activity. The reaction mixtures
(20 ml) contained 50mM Tris-HCl pH 7.5, 75mM NaCl, 5mM MgCl2 or 1mM
MnCl2, 1mM DTT, 2.5% glycerol, 0.1mgml 1 BSA, [a-32P] dATP (16 nM;
3,000 Cimmol 1) or [g-32P] ATP (16 nM; 3,000Cimmol 1), the indicated
amounts of each dNTP or NTP, in the presence of TthPrimPol (400 nM). After
60min at either 55 C or 30 C, as indicated, reactions were stopped by addition of
formamide loading buffer (10mM EDTA, 95% v/v formamide and 0.3% w/v xylene
cyanol). Reactions were loaded in 8M urea-containing 20% polyacrylamide
sequencing gels. After electrophoresis, de novo synthesized polynucleotides
(primers) were detected by autoradiography.
To evaluate the processivity of primer synthesis by TthPrimPol, we used
heparin as a competitor (Fig. 3c). TthPrimPol (10 nM) was pre-incubated for 5min
on ice in the previously described reaction buffer, either in the absence/presence of
heparin (1 ng ml 1). Subsequently, the reaction was complemented with M13mp18
ssDNA (5 ng ml 1), dATP, dCTP and dTTP (10 mM each), [a-32P] dGTP (16 nM;
3,000 Cimmol 1) and heparin (1 ng ml 1) when indicated, and the incubation
was maintained for 10min at 30 C and processed as described.
Primase/polymerase-coupled assay. A ‘Pulse and Chase’ experiment was
designed to analyse the extension by F29DNApol of the primers synthesized by
TthPrimPol in two consecutive stages (pulse and chase), as indicated in Fig. 3d.
During pulse, the reaction mixtures (20 ml; 50mM Tris-HCl pH 7.5, 75mM NaCl,
10mM MgCl2, 1mM DTT, 2.5% glycerol and 0.1mgml 1 BSA) containing
decreasing concentrations of TthPrimPol (100, 25 and 6.25 nM), [a-32P] dGTP
(16 nM), dATPþ dCTPþ dTTP (1 mM) and 5 ng ml 1 M13mp18 ssDNA were
incubated at 30 C during 20min. Half of the reaction was analysed as described for
the primase assays. During chase, a second half of the reaction was supplemented
with F29DNApol (50 nM) and the four unlabelled dNTPs (10 mM), to allow primer
extension for another 20min at 30 C. Then, the samples were processed as
described.
Rolling circle ampliﬁcation. M13mp18 circular ssDNA was used as input for the
TruePrime RCA kit workﬂow. Brieﬂy, DNA (2.5 ml; 40 fgml 1) was ﬁrst denatured
by adding 2.5 ml of alkaline buffer D and incubated 3min at room temperature. The
samples were then neutralized by adding 2.5 ml of buffer N. The ampliﬁcation mix
containing 9.3 ml of H2O, 2.5 ml of reaction buffer, 2.5 ml of dNTPs, 2.5 ml of
Enzyme 1 (TthPrimPol) and 0.7 ml of Enzyme 2 (F29DNApol) was added to the
DNA samples, resulting in a ﬁnal reaction volume of 25 ml. When indicated,
TthPrimPol was replaced by HsPrimPol or random synthetic primers (50 mM).
Reaction mixtures were incubated for 3 h at 30 C and F29DNApol was inactivated
for 10min at 65 C, to avoid degradation of the ampliﬁcation products. Ampliﬁed
DNA was quantiﬁed using the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen,
Life Technologies, Carlsbad, CA, USA) following the recommendations of the
manufacturer. Brieﬂy, samples were diluted 1:1,000 in 1 TE and, in parallel,
a DNA standard using human genomic DNA (Roche) with 1.6, 0.8, 0.4, 0.2 and
0.1 mgml 1 was prepared. Twenty microlitres of the sample or DNA standard
were transferred into a 96-well plate and 20 ml of PicoGreen working solution
(PicoGreen stock solution 1:150 diluted) was added. After gently shaking the
96-well plate, ﬂuorescence was measured in a Fluostar Microplate Reader (BMG
Labtech; excitation: 485 nm and emission: 520 nm). For measurements, duplicates
for each sample and DNA standard were performed, and DNA concentration was
determined from the human genomic DNA standard curve.
Whole genome ampliﬁcation. Six picograms (Fig. 4, part b) or different doses
ranging from 1 ng to 100 ag (Fig. 4, part d) of human genomic DNA (Promega)
were used as input in the reactions. Input DNA was subjected to the TruePrime
WGA kit workﬂow. Brieﬂy, DNA (2.5 ml) was ﬁrst denatured by adding 2.5 ml of
buffer D and incubating 3min at room temperature. The samples were then
neutralized by adding 2.5 ml of buffer N. The ampliﬁcation mix containing 26.8 ml
of H2O, 5 ml of reaction buffer, 5 ml of dNTPs, 5 ml of Enzyme 1 (TthPrimPol) and
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0.7 ml of Enzyme 2 (F29DNApol) was added to the DNA samples, resulting in a
ﬁnal reaction volume of 50ml. When indicated, TthPrimPol was replaced by the
same concentration of HsPrimPol or random synthetic primers (50mM). Reaction
mixtures were incubated for 3 h at 30 C and F29DNApol was inactivated for
10min at 65 C, to avoid degradation of the ampliﬁcation products. Ampliﬁed
DNA was quantiﬁed using the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen,
Life Technologies).
Single-cell WGA. We chose HEK293 cells for testing WGA protocols due to their
partial aneuploidic state51. Remark: HEK293 cells are listed as potentially
contaminated with HeLa cells in ICLAC (http://iclac.org/wp-content/uploads/
Cross-Contaminations-v7_2.pdf) based on a publication in 1981. The cells
analysed by us are clearly HEK293 cells based on their genomic sequence and CNV
proﬁle. The cell line has been obtained in 2010 from the DSMZ (Leibniz-Institute
German Collection of Microorganisms and Cell Cultures; DSMZ number:
ACC305). The cell line is regularly checked for mycoplasma contamination by a
PCR assay (primer A: 50-ggc gaa tgg gtg agt aac acg-30 and primer B: 50-cgg ata acg
ctt gcg acc tat-30).
HEK293 cells were washed with 1 PBS, followed by incubation with
Trypsin-EDTA solution (Gibco). After resuspending cells with culture medium,
they were spun down and washed again with 1 PBS. After preparing three serial
dilutions of cells in 1 PBS, they were counted, diluted to a ﬁnal concentration of
1 cell per 2.5 ml 1 PBS. This volume was dispensed into clear-well plates and
visually inspected. TruePrime Single Cell WGA kit workﬂow was followed to
amplify the genomic DNA of each cell. Brieﬂy, 2.5 ml of lysis buffer L2 were added,
followed by incubation for 10min on ice. To neutralize the lysis buffer, 2.5 ml of
neutralization buffer N were added. The ampliﬁcation mix containing 26.8 ml of
H2O, 5 ml of reaction buffer, 5 ml of dNTPs, 5 ml of Enzyme 1 (TthPrimPol) and
0.7 ml of Enzyme 2 (F29DNApol) was added to the neutralized samples, resulting
in a ﬁnal reaction volume of 50 ml. The reaction mixtures were incubated for 3 or
6 h at 30 C, followed by inactivation of F29DNApol for 10min at 65 C. To obtain
NA reference DNA, genomic DNA was extracted from HEK293 cells using
QIAamp genomic DNA extraction kits (Qiagen). DNA concentration was
determined by the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen, Life
Technologies). For ampliﬁcation with the REPLI-g single-cell kit (Qiagen;
commercial random primed MDA) and with the MALBAC protocol Single Cell
WGA kit (Yikon Genomics), instructions of the manufacturers were followed.
Sequencing. After ampliﬁcation, DNA was precipitated by ethanol precipitation.
DNA fragmentation (Covaris), library preparation using NebNext (NEB) and
paired end sequencing (HiSeq 2500, v4 chemistry, HiSeq Control Software, Version
2.2.58, Real-Time Analysis, Version 1.18.64 and Sequence Analysis Viewer,
Version 1.8.46, Casava Version 1.8.2) were performed at GATC Biotech, Konstanz,
Germany. FastQ ﬁles were obtained and further processed.
Bioinformatic and statistical analyses. Quality assessment and mapping. CLC
Genomic Workbench Version 8.5 (Qiagen) was used for main analyses of NGS
data sets (alignment and mapping parameters). Illumina BaseSpace FASTQC
v1.0.0 was used for sequencing quality assessment and GC content dependency
calculations. Circos plots were generated using the Circos framework66.
Saturation of coverage breadth. For each 20 sample, a calculated number of
aligned reads were selected with samtools view function from bam ﬁles to produce
the desired read depth (0.1 , 0.25 , 0.5 , 0.75 , 1 , 2 , 3 , 4 , 5 ,
10 and 15 ). The fraction of single read coverage and the fraction of tenfold
coverage was calculated with bedtools genomeCoverageBed function.
SNV calling and analyses. All SNV callers were applied to the same aligned
sequence data set (BAM ﬁles aligned to hg19 with an overall coverage (mapped
reads) of B19–20 of the human genome).
CLC Genomics Workbench 9.0 low-frequency variant detection caller67 was
used with the following stringent settings (required signiﬁcance (%)¼ 1.0, ignore
positions with coverage above¼ 1,000, restrict calling to target regions¼ not set,
ignore broken pairs¼ yes, ignore nonspeciﬁc matches¼ reads, minimum
coverage¼ 10, minimum count¼ 3, minimum frequency (%)¼ 5.0, base quality
ﬁlter¼ yes, neighbourhood radius¼ 5, minimum central quality¼ 20, minimum
neighbourhood quality¼ 15, read direction ﬁlter¼ yes, direction frequency
(%)¼ 10.0, relative read direction ﬁlter¼ yes, signiﬁcance (%)¼ 1.0, read position
ﬁlter¼ yes, signiﬁcance (%)¼ 1.0, remove pyro-error variants¼ no).
Samtools 1.368—mpileup/bcftools, htslib 1.3.1 was used with -E and -uf settings.
Bcftools 1.3.1 was used with -cv, -Ov and --ploidy¼GRCh37.
VarScan2.v2.4.169 was used with standard settings.
Isaac Variant Caller 1.0.770 was used with the (standard) settings:
isSkipDepthFilters¼ 0, maxInputDepth¼ 10,000, depthFilterMultiple¼ 3.0,
indelMaxRefRepeat¼  1, minMapq¼ 20, minGQX¼ 30,
isWriteRealignedBam¼ 0, binSize¼ 25000000CLC. The Isaac variant caller uses
the GATK Uniﬁed Genotyper followed by ﬁltering with the variant quality score
recalibration (VQSR) protocol71.
SNV intersection analyses were done with Illumina BaseSpace VCAT
(Variant Calling Assessment Tool v2.3.0.0) and Illumina VariantStudio v2.2.4
(https://basespace.illumina.com/home/index). Estimated ADO rate was determined
over the whole genome using R v3.3.0 by determining the number of variants in the
overlapping set of SNVs that were heterozygote in the NA sample and homozygote
in the ampliﬁed samples and assuming an equal number of heterozygote to
homozygote conversions that were not contained in the overlap set because of
reversion to the reference allele.
SNV false positive rates. For the estimation of the FPR for each SNV caller all
called SNVs from the NA sample were assumed as true SNVs. Thus:
TP ¼ sample\ control
FP ¼ Number of SNVsin sampleTP
FN ¼ Number of SNVs inTP
TN ¼ Number of positions in human genomeðTPþ FPÞ
FPR ¼ FP
FPþTN
Position based recall and precision (calculated by V-CAT). Recall and
precision were calculated by the VCF Gold Standard Comparison with NIST
Genome in a Bottle integrated calls v0.2.
Recall ¼ TP
TPþ FN Precision ¼
TP
TPþ FP
CNV calling. CNV analyses were done using Ginkgo)55 (http://qb.cshl.edu/ginkgo/)
or ControlFreeC54 (http://bioinfo-out.curie.fr/projects/freec/).
K-mer frequency analyses. K-mers were calculated with jellyﬁsh49. K-mer size
was set to 1,950. An estimation of genome sizes from k-mer counts were calculated
by the bin sizes B, the corresponding frequency F and the peak depth estimated
from the k-mer distribution: E ¼
P
BF
P . The single-copy region was extracted
visually as the ﬁrst peak after the initial error peak at bin size 1.
Statistical analyses. Additional statistical analyses were done using JMP 12
(SAS Institute, Heidelberg, Germany) or R v3.3.0 /Rstudio v0.99.902. A P-value
o0.05 was considered signiﬁcant.
Data availability. The data sets generated during and analysed during the current
study are available in the GenBank Sequence Read Archive, accession number
SRP085855.
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